Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders

OBJECTIVE: Therapeutic drug monitoring helps clinicians in choosing the right drug and adjust its dose in specific patients. To this end, we aimed to assess time patterns of risperidone and its metabolite, 9-hydroxyrisperidone, in children and adolescents with oppositional defiant and/or conduct dis...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Psychopharmacol Neurosci
Päätekijät: Piacentino, Daria, Kotzalidis, Georgios D., Schoretsanitis, Georgios, Paulzen, Michael, Haen, Ekkehard, Cappelletti, Simone, Giupponi, Giancarlo, Grözinger, Michael, Conca, Andreas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean College of Neuropsychopharmacology 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006987/
https://ncbi.nlm.nih.gov/pubmed/31958904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.41
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia